Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 8 April 2024, 12:45 HKT/SGT
Share:
    

Source: NEC Corporation
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines

TOKYO, Apr 8, 2024 - (JCN Newswire) - NEC Corporation (TSE: 6701) has released a white paper, "Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines". This white paper introduces (1) a comprehensive process workflow that can be applied to a wide range of processes, starting from tumor sample collection to vaccine design, manufacturing, supply, and administration, (2) important perspectives for consideration in the workflow, and (3) advanced technologies that will contribute to the realization of the workflow.

Click here for details and downloads (registration is not required)URL: www.nec.com/en/global/solutions/ai-drug/publication/index.html

NEC is committed to taking on the challenge of realizing new cancer treatments by aiming to establish an accurate, reliable, and comprehensive process workflow that utilizes AI and security technologies.

In recent years, there have been growing expectations for personalized neoantigen cancer vaccines as a next-generation cancer therapy. Personalized neoantigen cancer vaccines are a type of cancer immunotherapy that targets neoantigens containing genomic mutations that are specific to each patient. NEC is working on the realization of personalized cancer vaccines by using one of its core technologies, AI, to identify target neoantigens from each individual patient’s genome data.

This white paper proposes a comprehensive process workflow for personalized cancer vaccines, from design to administration, and the perspectives that should be discussed in this flow. Furthermore, NEC's advanced ICT technologies are introduced to address these perspectives, and the possibility that the use of ICT technology will contribute to the realization of a platform for not only personalized cancer vaccines, but also for various cancer treatments are discussed.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com.




Topic: Press release summary
Source: NEC Corporation

Sectors: MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


NEC Corporation Links

http://www.nec.com

https://www.facebook.com/nec.global/

https://twitter.com/NEC_corp

https://www.youtube.com/user/NECglobalOfficial

https://www.linkedin.com/company/nec/

NEC Corporation
June 2, 2025 16:56 HKT/SGT
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 months with Individualized Cancer Vaccine TG4050
May 30, 2025 09:11 HKT/SGT
IFS and NEC Strengthen their Strategic Partnership to Create New Value
Apr 28, 2025 15:03 HKT/SGT
NEC DGDF Headquarters relocates to Zurich to accelerate growth and enhance management globally
Apr 24, 2025 09:23 HKT/SGT
NEC invests in U.S.-based "Geodesic Alliance Fund" aiming to strengthen economic security business
Apr 9, 2025 10:09 HKT/SGT
NEC Face Recognition Ranks First in NIST Accuracy Testing
Apr 8, 2025 15:42 HKT/SGT
NEC Orchestrating Future Fund invests in Rescale, Inc., provider of a leading digital engineering platform for cloud high-performance computing (HPC)
Apr 8, 2025 15:11 HKT/SGT
SITA and NEC Collaborate to Drive Global Adoption of Digital Identities in Travel
Apr 1, 2025 15:15 HKT/SGT
NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
Mar 28, 2025 12:08 HKT/SGT
NEC and COEDO Brewery develop the second edition of "The taste of life created by brewers and AI -- Agentic AI x Craft Beer"
Mar 26, 2025 13:41 HKT/SGT
NEC provides 25G tunable SFP extended reach optical transceiver
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: